Equities

Cannabis Bioscience International Holdings Inc

CBIH:PKC

Cannabis Bioscience International Holdings Inc

Actions
IndustrialsConstruction and Materials
  • Price (USD)0.0007
  • Today's Change0.000 / -12.50%
  • Shares traded7.33m
  • 1 Year change+75.00%
  • Beta-0.1807
Data delayed at least 15 minutes, as of Sep 20 2024 16:49 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of May 31 2011201120102009
ASSETS
Cash And Short Term Investments0.141.100.92
Total Receivables, Net315426
Total Inventory0.350.580.89
Prepaid expenses----0
Other current assets, total0.010.150
Total current assets325628
Property, plant & equipment, net8.908.005.65
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term356.240.95
Other long term assets151.290
Total assets937235
LIABILITIES
Accounts payable131311
Accrued expenses0.980.490.28
Notes payable/short-term debt01.320
Current portion long-term debt/capital leases3.171.950
Other current liabilities, total9.902.221.73
Total current liabilities271913
Total long term debt0.522.190
Total debt3.695.450
Deferred income tax------
Minority interest2.902.051.21
Other liabilities, total------
Total liabilities312414
SHAREHOLDERS EQUITY
Common stock43421.40
Additional paid-in capital------
Retained earnings (accumulated deficit)154.3218
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total4.111.511.73
Total equity624821
Total liabilities & shareholders' equity937235
Total common shares outstanding13131.53
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.